Ross Osborn Stock Analyst Profile - Cantor Fitzgerald Research Coverage - Stocknear

Ross Osborn

Stock Analyst at Cantor Fitzgerald

(3.4)
# 2750
Out of 5,506 analysts
127
Total ratings
Success rate
Average return

25 Stocks

Name Action PT Current % Upside Ratings Updated
ORGO Organogenesis Holdin...
Maintains: Overweight
7 9
4.29 109.79% 4 Aug 8, 2025
LMAT LeMaitre Vascular
Maintains: Neutral
92 95
87.85 8.14% 2 Aug 6, 2025
CVRX CVRx
Reiterates: Overweight
11 11
8.71 26.29% 3 Aug 5, 2025
SIBN SI-BONE
Reiterates: Overweight
25 25
14.5 72.41% 10 Aug 5, 2025
MDXG MiMedx Group
Maintains: Overweight
11 12
7.21 66.44% 5 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
12
7.02 70.94% 1 Jul 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
8 7
10.96 -36.13% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
2 2
1.04 92.31% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
17 17
10.92 55.68% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
12 9
3.93 129.01% 11 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
46 46
31.19 47.48% 6 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8 8
0.88 809.09% 10 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
24 24
17.88 34.23% 3 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.57 154.78% 4 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
9 9
14.27 -36.93% 7 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
4.31 108.82% 1 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
21 21
5.54 279.06% 10 Dec 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
16 16
4.95 223.23% 4 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.49 134.9% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
0.64 290.62% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 7 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
4 4
n/a n/a 5 Apr 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
9
n/a n/a 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 21
n/a n/a 2 Apr 22, 2022